Letter Agreement, dated June 17, 2024, by and between University of Southern California, and NeOnc Technologies, Inc

EX-10.10 20 neonctechnologies_ex10-10.htm EXHIBIT 10.10

 

Exhibit 10.10

 

 

 

June 17, 2024

 

Keithly Garnett

Chief Financial Officer

NeOnc Technologies, Inc.

8335 West Sunset Blvd.

Suite 240

Los Angeles, California 90069-1500

 

Re: Amended and Restated Exclusive License Agreement, effective November 20, 2023, between University of Southern California (“USC”) and NeOnc Technologies, Inc. (“NeOnc”) (the “License Agreement”)

 

Dear Keithly:

 

This Letter Agreement reflects the agreement of USC and NeOnc to amend the License Agreement as provided herein.

 

NeOnc acknowledges that it owes USC $230,000 of past liabilities pursuant to the License Agreement as of the date of this letter. NeOnc shall pay this amount plus $20,000 to USC (a total of $250,000) on the earlier of (i) June 1, 2025 or (ii) within five (5) business days of NeOnc’s1 first underwritten (firm commitment) public offering of shares or other equity pursuant to a registration statement filed with the Securities and Exchange Commission (the “SEC”) (but excluding any registration statement relating either to the sale of securities to employees of NeOnc pursuant to a stock option, stock purchase or similar plans or a business combination transaction of the type contemplated by Rule 145 promulgated by the SEC under the Securities Act of 1933, as amended) (an “IPO”).

 

The foregoing arrangements with respect to past liabilities does not in any way alter or forgive any payment obligations that arise under the License Agreement on or after the date of this letter, whether with respect to royalties, sublicense payments, or otherwise.

 

Any breach by NeOnc of this letter agreement shall be deemed a breach of the License Agreement. Except as expressly set forth herein, the License Agreement remains in full force and effect.

 

 

 
1 NTD: NeOnc to confirm whether NeOnc, NeOnc Technologies Holding, Inc., or a different affiliated entity is planning the IPO.

 

 

 

 

Please confirm NeOnc’s acceptance of the terms of this letter agreement by countersigning a copy of this letter and returning it to me. Thank you for your assistance.

 

  Very truly yours,
   
  /s/ Erin Overstreet
  Erin Overstreet, PhD
   
  Executive Director
  USC Stevens Center for Innovation

 

cc: Bonnie Wolfe
  Christina Falcone
  Roberta Hunt

 

UNDERSTOOD AND AGREED TO:  
     
NeOnc Technologies, Inc.  
     
By: /s/ Thomas Chen, MD  
Name: Thomas Chen, MD  
Title: Chief Executive Office and Chairman  
Date: 6/17/2024  

 

NeOnc Technologies Holdings, Inc.  
     
By: /s/ Keithly A. Garnett  
Name: Keithly A. Garnett  
Title: Chief Financial Officer  
Date: 6/17/2024  

 

NeOnc Technologies Holdings, Inc.  
     
By: /s/ Amir F. Heshmatpour  
Name: Amir F. Heshmatpour  
Title: Executive Chairman  
Date: 6/17/2024